Amgen Inc. – ‘8-K’ for 3/4/21 – ‘EXCEL’

On:  Thursday, 3/4/21, at 8:39am ET   ·   For:  3/4/21   ·   Accession #:  1193125-21-68571   ·   File #:  1-37702

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     49K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    322K 
                Liquidation or Succession                                        
 3: EX-99.1     Miscellaneous Exhibit                               HTML     31K 
 9: R1          Document and Entity Information                     HTML     53K 
11: XML         IDEA XML File -- Filing Summary                      XML     13K 
 8: XML         XBRL Instance -- d151856d8k_htm                      XML     21K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.DEF  XBRL Definitions -- amgn-20210304_def                XML     42K 
 6: EX-101.LAB  XBRL Labels -- amgn-20210304_lab                     XML     68K 
 7: EX-101.PRE  XBRL Presentations -- amgn-20210304_pre              XML     43K 
 4: EX-101.SCH  XBRL Schema -- amgn-20210304                         XSD     15K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    22K 
13: ZIP         XBRL Zipped Folder -- 0001193125-21-068571-xbrl      Zip    102K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/03/21  Amgen Inc.                        10-Q        9/30/21   80:11M
 8/06/21  Amgen Inc.                        424B2                  1:596K                                   Donnelley … Solutions/FA
 8/05/21  Amgen Inc.                        424B3                  1:577K                                   Donnelley … Solutions/FA
 8/04/21  Amgen Inc.                        10-Q        6/30/21   79:11M
 4/28/21  Amgen Inc.                        10-Q        3/31/21   74:8.3M
 4/16/21  Amgen Inc.                        8-K:2,7,9   4/16/21   12:221K                                   Donnelley … Solutions/FA
 4/15/21  Amgen Inc.                        424B3                  1:317K                                   Donnelley … Solutions/FA
 3/18/21  Amgen Inc.                        SC TO-T               11:1.1M Five Prime Therapeutics, Inc.     Donnelley … Solutions/FA